UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.
Madreiter-Sokolowski CT, Győrffy B, Klec C, Sokolowski AA, Rost R, Waldeck-Weiermair M, Malli R, Graier WF.
Madreiter-Sokolowski CT, et al. Among authors: graier wf.
Oncotarget. 2017 Aug 28;8(46):80278-80285. doi: 10.18632/oncotarget.20571. eCollection 2017 Oct 6.
Oncotarget. 2017.
PMID: 29113301
Free PMC article.